Hee Jung Jeon1,2, Yong Chul Kim1, Seokwoo Park1, Clara Tammy Kim3, Jongwon Ha4, Duck Jong Han5, Jieun Oh2, Chun Soo Lim1, In Mok Jung6, Curie Ahn1, Yon Su Kim1, Jung Pyo Lee7,1, Young Hoon Kim8. 1. Departments of Internal Medicine and. 2. Department of Internal Medicine, Kangdong Sacred Heart Hospital. 3. Graduate School of Public Health, Seoul National University. 4. Surgery, Seoul National University College of Medicine. 5. Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, and. 6. Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. 7. Departments of Internal Medicine and nephrolee@gmail.com kyh-001@hanmail.net. 8. Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, and nephrolee@gmail.com kyh-001@hanmail.net.
Abstract
BACKGROUND AND OBJECTIVES: Hyperphosphatemia in kidney transplant recipients has been shown to predict poorer graft and patient survival. However, studies examining hypophosphatemia are scarce. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To evaluate the association of serum phosphorus level with patient and graft survival, we performed a retrospective multicenter cohort study. Between January of 1997 and August of 2012, 2786 kidney transplant recipients (41.7±11.4 years; 59.3% men; 73.5% living donors; 26.1% with diabetes; 3.8% with prior history of cardiovascular disease) were classified into seven groups according to serum phosphorus levels 1 year after transplantation, with intervals of 0.5 mg/dl (lowest group, <2.5 mg/dl; highest group, ≥5.0 mg/dl; reference group, 3.5-3.99 mg/dl). Survival analysis was performed by defining baseline time point as 1 year after transplantation. RESULTS: During median follow-up of 78.5 months, 60 patient deaths and 194 cases of graft loss occurred. In multivariate analysis, both lowest and highest serum phosphorus groups were associated with higher mortality, compared with the reference group (hazard ratio [HR], 4.82; 95% confidence interval [95% CI], 1.36 to 17.02; P=0.01; and HR, 4.24; 95% CI, 1.07 to 16.84; P=0.04, respectively). Higher death-censored graft loss was observed in the lowest and highest groups (HR, 3.32; 95% CI, 1.42 to 7.79; P=0.01; and HR, 2.93; 95% CI, 1.32 to 6.49; P=0.01, respectively), despite eGFR exhibiting no difference between the lowest group and reference group (65.4±19.3 versus 61.9±16.7 ml/min per 1.73 m2; P=0.33). Moreover, serum phosphorus showed a U-shape association with patient mortality and graft failure in restricted cubic spline curve analysis. CONCLUSIONS: Serum phosphorus level 1 year after transplantation exhibits a U-shape association with death-censored graft failure and patient mortality in kidney transplant patients characterized by relatively high rate of living donor transplant and low incidence of diabetes and prior cardiovascular disease compared with Western countries.
BACKGROUND AND OBJECTIVES:Hyperphosphatemia in kidney transplant recipients has been shown to predict poorer graft and patient survival. However, studies examining hypophosphatemia are scarce. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To evaluate the association of serum phosphorus level with patient and graft survival, we performed a retrospective multicenter cohort study. Between January of 1997 and August of 2012, 2786 kidney transplant recipients (41.7±11.4 years; 59.3% men; 73.5% living donors; 26.1% with diabetes; 3.8% with prior history of cardiovascular disease) were classified into seven groups according to serum phosphorus levels 1 year after transplantation, with intervals of 0.5 mg/dl (lowest group, <2.5 mg/dl; highest group, ≥5.0 mg/dl; reference group, 3.5-3.99 mg/dl). Survival analysis was performed by defining baseline time point as 1 year after transplantation. RESULTS: During median follow-up of 78.5 months, 60 patient deaths and 194 cases of graft loss occurred. In multivariate analysis, both lowest and highest serum phosphorus groups were associated with higher mortality, compared with the reference group (hazard ratio [HR], 4.82; 95% confidence interval [95% CI], 1.36 to 17.02; P=0.01; and HR, 4.24; 95% CI, 1.07 to 16.84; P=0.04, respectively). Higher death-censored graft loss was observed in the lowest and highest groups (HR, 3.32; 95% CI, 1.42 to 7.79; P=0.01; and HR, 2.93; 95% CI, 1.32 to 6.49; P=0.01, respectively), despite eGFR exhibiting no difference between the lowest group and reference group (65.4±19.3 versus 61.9±16.7 ml/min per 1.73 m2; P=0.33). Moreover, serum phosphorus showed a U-shape association with patient mortality and graft failure in restricted cubic spline curve analysis. CONCLUSIONS: Serum phosphorus level 1 year after transplantation exhibits a U-shape association with death-censored graft failure and patient mortality in kidney transplant patients characterized by relatively high rate of living donor transplant and low incidence of diabetes and prior cardiovascular disease compared with Western countries.
Authors: David Benavente; Colin D Chue; Jason Moore; Clara Addison; Richard Borrows; Charles J Ferro Journal: Exp Clin Transplant Date: 2012-04 Impact factor: 0.945
Authors: Elke S Schaeffner; Manuela Födinger; Reinhard Kramar; Gere Sunder-Plassmann; Wolfgang C Winkelmayer Journal: Transpl Int Date: 2007-03 Impact factor: 3.782
Authors: Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra Journal: J Am Soc Nephrol Date: 2008-11-05 Impact factor: 10.121
Authors: Christian S Shinaberger; Sander Greenland; Joel D Kopple; David Van Wyck; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh Journal: Am J Clin Nutr Date: 2008-12 Impact factor: 7.045
Authors: Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler Journal: Nephrol Dial Transplant Date: 2010-04-25 Impact factor: 5.992
Authors: Marco van Londen; Brigitte M Aarts; Petronella E Deetman; Jessica van der Weijden; Michele F Eisenga; Gerjan Navis; Stephan J L Bakker; Martin H de Borst Journal: Clin J Am Soc Nephrol Date: 2017-05-25 Impact factor: 8.237
Authors: Julio Chevarria; Donal J Sexton; Susan L Murray; Chaudhry E Adeel; Patrick O'Kelly; Yvonne E Williams; Conall M O'Seaghdha; Dilly M Little; Peter J Conlon Journal: Clin Kidney J Date: 2020-05-22